Kirti Kulkarni
- Cancer Research top 10%
- Breast Cancer Treatment Studies 3
- MicroRNA in disease regulation 2
-
- Breast Lesions and Carcinomas 6
-
- MRI in cancer diagnosis 9
- Radiomics and Machine Learning in Medical Imaging 5
- Medical Imaging Techniques and Applications 4
- Emergency Medicine top 10%
-
- Global Cancer Incidence and Screening 2
-
- Cerebrospinal fluid and hydrocephalus 2
- Co-authors
- Hiroyuki AbéCharlene A. SennettGillian M. NewsteadRobert A. SchmidtAytekin OtoGregory S. KarczmarDavid T. RubinJerrold R. Turner
- Partner nations
- United StatesIndiaAustralia
In The Last Decade
Kirti Kulkarni
24 papers receiving 779 citations
Peers
Comparison fields: 5 of 67
- Cancer Research 251
- Pathology and Forensic Medicine 295
- Radiology, Nuclear Medicine and Imaging 356
- Emergency Medicine 63
- Surgery 228
Countries citing papers authored by Kirti Kulkarni
This map shows the geographic impact of Kirti Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kirti Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kirti Kulkarni more than expected).
Fields of papers citing papers by Kirti Kulkarni
This network shows the impact of papers produced by Kirti Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kirti Kulkarni. The network helps show where Kirti Kulkarni may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kirti Kulkarni, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 2 | |
| 4 | 2023 | 4 | |
| 5 | 2023 | 15 | |
| 6 | 2019 | 14 | |
| 7 | 2019 | 9 | |
| 8 | 2019 | 8 | |
| 9 | 2019 | 14 | |
| 10 | 2017 | 4 | |
| 11 | 2017 | 20 | |
| 12 | 2017 | 16 | |
| 13 | 2014 | 11 | |
| 14 | 2014 | 4 | |
| 15 | 2013 | 39 | |
| 16 | 2011 | 10 | |
| 17 | 2010 | 146 | |
| 18 | 2009 | 184 | |
| 19 | 2008 | 149 | |
| 20 | 2001 | 23 |
About Kirti Kulkarni
Kirti Kulkarni is a scholar working on Radiology, Nuclear Medicine and Imaging, Pathology and Forensic Medicine and Cancer Research, having authored 25 papers that have together received 791 indexed citations. Recurring topics across this work include MRI in cancer diagnosis (9 papers), Breast Lesions and Carcinomas (6 papers), Radiomics and Machine Learning in Medical Imaging (5 papers), Medical Imaging Techniques and Applications (4 papers), Breast Cancer Treatment Studies (3 papers), Global Cancer Incidence and Screening (2 papers), Cerebrospinal fluid and hydrocephalus (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (251 citations), Pathology and Forensic Medicine (295 citations) and Radiology, Nuclear Medicine and Imaging (356 citations). Kirti Kulkarni has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Hiroyuki Abé, Charlene A. Sennett, Gillian M. Newstead, Robert A. Schmidt, Aytekin Oto, Gregory S. Karczmar, David T. Rubin, Jerrold R. Turner, Jeffrey Mueller and Rajshri N. Shah. Their work appears in journals such as Scientific Reports, Radiology and Neurosurgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.